Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Several states are trying to reduce healthcare costs by importing medicine from countries where it costs less, but this is a deeply flawed policy proposal.

Pharmacy Benefit Managers' under-reimbursements make pharmacies perfect targets for counterfeiters—and make the U.S. drug supply less safe as a result.

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

September 30, 2024: 27 individuals indicted in Puerto Rico over wholesale distribution of misbranded and diverted medicine

September 30, 2024

Twenty-seven people in Puerto Rico indicted in misbranded and diverted drug case, CBP seized counterfeit and misbranded drugs in two states, and fake arthritis and cancer medications seized in India.

PSM Compounded Weight Loss Drugs Poll

September 26, 2024

PSM commissioned a survey about compounded diabetes and weight loss injectable drugs. 1,000 likely voters across political affiliations were crystal clear — they are worried about safety and the current lack of oversight. See the full results.

September 23, 2024: Administrative complaint filed alleging insulin price inflation by pharmacy benefit managers

September 23, 2024

The Federal Trade Commission issued an administrative complaint against the three largest pharmacy benefit managers, alleging that the companies used their market power to inflate the cost of insulin for U.S. patients.

FDA Alert: Herbal Supplement Recalled for Containing Prescription Steroids and OTC Antihistamines

September 23, 2024

If used chronically at the recommended dose, dexamethasone could cause severe and serious adverse events such as adrenal suppression (a disorder in which the adrenal glands do not produce enough hormones), central nervous system and psychiatric/behavioral effects, weight gain, gastrointestinal effects, elevated blood glucose, increased infection risks, neuromuscular and skeletal side effects, ocular effects, cardiovascular effects, dermatologic effects endocrine and metabolic issues, among other adverse events not mentioned.

September 16, 2024: An ongoing lawsuit suggests peril for pharmacy-to-pharmacy market place users

September 16, 2024

Rxeed’s suit of CVS Caremark alleges predatory practices against independent pharmacies. Walgreens joins up with NABP’s Pulse. Stories about medicine safety in the U.S. and around the world.

September 9, 2024: A Mexican pharmacy sold a Texas man a known Ozempic counterfeit

September 9, 2024
a comparison of real and fake Ozempic pens sold in Germany.

Reuters writes about fake Ozempic and medicine tracking. The U.S. FDA issues warnings about supplements that contain undeclared prescription medicine. Additional news in India and Nigeria.

Like your information on video? Subscribe to our YouTube playlist!

Find out why dosing errors are a problem for people taking compounded semaglutide.

youtube-video-thumbnail

Are your injected diabetes and weight-loss meds safe? Watch

youtube-video-thumbnail

The CAST Act would make counterfeiting controlled substance pills a federal crime. Learn why that's important.

Click the images below to see more recent videos.